GL1X · GenesisL1 explorer

MolNFT v1 · #99509 · protein

The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase

4M5K · 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine…: “The identification, analysis and structure-based development of novel inhibitors of…”. X-ray diffraction, 3 ligands (APC, YH3, CA), 2 pockets (best druggability 0.63). MolNFT v1…

PDB
4M5K
Type
protein
Length
159 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase
EC
2.7.6.3
UniProt
P26281
Ligands
APC, YH3, CA
Pockets
2 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase (EC 2.7.6.3)protein15930% helix, 27% strandP26281

Ligands and binding sites

  • APC · Diphosphomethylphosphonic acid adenosyl ester · ligand · chains A
  • YH3 · 2-amino-8-{[2-(3-methylphenyl)-2-oxoethyl]sulfanyl}-1,9-dihydro-6H-purin-6-one · ligand · chains A
  • CA · Calcium ion · metal · 3 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13250.630.7942APC, CA, YH3, GOL
2530.320.7714empty

Compared structures

  • 4M5K · The Identification, Analysis and Structure-Based Development of Novel Inhibitors of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.